Better Therapeutics, Inc. BTTX

Set alert

Price alert · BTTX

All alert types
0.00 USD 0.00 0.00%

At close · Oct 30

0.0001 Day range 0.0001
0.0001 52-week range 0.0002
YTD
0.00%
1 year
0.00%
Open
0.0001
Prev close
0.0001
Mkt cap
5.45K
Vol
500
Avg vol
4.19K
EPS
-0.37
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0001
High
0.0001
Forward P/E
-0.01
Beta
2.13
Short ratio
0.94
Inst. own
2.95%
Dividend
0.00
Ex-div date
Earnings
Dec 26, 2024
50-d avg
0.11514
200-d avg
0.349255
1y target
5.25

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for BTTX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: buy

Buy
Price target (mean) 5.25 +5249900.0% upside
Target (low)
1.50
Target (mean)
5.25
Target (high)
9.00

Recommendation trend

  • 1 month ago 2
  • 2 months ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BTTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.12-0.12 – -0.12-0.37+67.6%00.0%1
Next quarter0.000.00 – 0.00-0.390.0%00.0%0
Current year-0.81-0.81 – -0.81-1.69+52.1%00.0%1
Next year-1.00-1.00 – -1.00-0.81-23.5%3.80M0.0%1

Upgrades and downgrades

The latest rating changes

BTTX analyst upgrades and downgrades
DateFirmActionFromTo
Aug 9, 2023Chardan CapitalReiteratedBuyBuy
Aug 9, 2023Lake StreetMaintainedBuyBuy
Apr 13, 2023Lake StreetMaintained—Buy
Mar 30, 2023Chardan CapitalMaintained—Buy
Nov 14, 2022Chardan CapitalMaintained—Buy
Jul 28, 2022Chardan CapitalMaintained—Buy
Mar 15, 2022Chardan CapitalMaintained—Buy
Nov 23, 2021Chardan CapitalInitiated—Buy
Nov 9, 2021Cowen & Co.Initiated—Outperform